Brief introduction: Biotechnology Company is committed to developing a new generation of antibody drugs to treat major diseases that endanger human life, including tumors, cardiovascular diseases and autoimmune diseases. At present, the company is developing more than 10 products, among which the national 1. 1 new drug Batifiban independently developed by the company has completed phase III clinical research.
Legal Representative: Yi
Date of establishment: July 28, 2003
Registered capital: 1053 16489 RMB.
Industrial and commercial registration number: 440 10840000443 1
Type of enterprise: other limited liability companies
Company address: 5th floor, Building A6, Kaiyuan Avenue 1 1, Science City, Guangzhou High-tech Industrial Development Zone.